Optimizing heart failure medications after valve procedure
Part of Heart & circulation clinical trials.
This study tests whether increasing the doses of standard heart failure medicines shortly after a catheter-based heart valve procedure improves recovery and long-term heart function. It is designed for people with heart failure who had a valve fixed during this hospital stay.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You are hospitalized with severe heart valve disease (like aortic stenosis or mitral regurgitation) and had a catheter-based valve repair or replacement (not open surgery).
- You have heart failure with reduced ejection fraction (a weak heart pump).
- Before discharge, your blood pressure and heart rate are stable, and your potassium level is within range.
- You are currently on less than half the target dose of certain heart failure medicines (like ACE inhibitors, ARBs, beta-blockers, or aldosterone blockers).
- You live in the Lombardy region of Italy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether starting two heart failure medications later, after a procedure to fix the heart's problem, is safe and helpful. It aims to see if waiting a bit can still improve heart function and quality of life.
This study looks at how the heart adjusts after a procedure to replace the tricuspid valve (the valve between the right upper and lower heart chambers). It focuses on patients who need medication to support their blood pressure within 24 hours after the procedure, to better understand and manage this unstable period.
This study looks at how well the new heart valve works after a TAVI procedure, using pressure measurements to see if blood flow improves. It aims to confirm that the treatment is effective for people with severe aortic stenosis.
This study checks how well certain heart valve devices work in real life for people who have already been treated. It helps doctors learn if these devices are safe and helpful over time.
This trial tests if special pacing of the heart's lower chambers (called cardiac resynchronization therapy, or CRT) can help people who develop a new electrical delay in the heart after having a transcatheter aortic valve replacement (TAVI). The study compares two types of pacing to see which works better for recovery.
This trial tests whether repairing a leaky heart valve (mitral valve) can help people with heart failure feel better and live longer, even when standard heart failure medicines are not working well. The repair is done through a small tube in a blood vessel, avoiding open-heart surgery.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.